Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HEMOPHILIA B”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06611436
What this trial is testing

BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

Who this might be right for
Hemophilia BHemophilia B, Moderately Severe or Severe
Be Biopharma 5
Not applicableUnknownNCT03287999
What this trial is testing

Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B

Who this might be right for
Haemophilia
Royal Free Hospital NHS Foundation Trust 250
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Not applicableStudy completedNCT03901755
What this trial is testing

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Swedish Orphan Biovitrum 151
Not applicableStudy completedNCT00835068
What this trial is testing

Post Marketing Observational Study of Reformulated BeneFIX

Who this might be right for
Hemophilia B
Pfizer 58
Testing effectiveness (Phase 2)UnknownNCT02463591
What this trial is testing

Reversal of Dabigatran With Prothrombin Complex Concentrate

Who this might be right for
Drug Action Reversal
University Medical Center Groningen 12
Not applicableStudy completedNCT05804734
What this trial is testing

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

Who this might be right for
Hemophilia AHemophilia BAnticoagulant-induced Bleeding
Groupe Maladies hémorragiques de Bretagne 54
Not applicableWithdrawnNCT02429453
What this trial is testing

FFP Versus PCC in Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage, TraumaticIntracranial Hemorrhage, Spontaneous
University of Utah
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Not applicableStudy completedNCT02937831
What this trial is testing

RIXUBIS Drug Use-Result Survey (Japan)

Who this might be right for
Hemophilia B
Baxalta now part of Shire 6
Large-scale testing (Phase 3)Active Not RecruitingNCT04083781
What this trial is testing

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

Who this might be right for
Haemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 134
Large-scale testing (Phase 3)Study completedNCT00093171
What this trial is testing

Study Evaluating rFIX; BeneFIX® in Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 23
Testing effectiveness (Phase 2)Ended earlyNCT00076557
What this trial is testing

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

Who this might be right for
Hemophilia B
Avigen 15
Post-approval studies (Phase 4)Study completedNCT00139828
What this trial is testing

Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)

Who this might be right for
Hemophilia B
Prothya Biosolutions 12
Not applicableActive Not RecruitingNCT05086575
What this trial is testing

Observatory of Patients With Haemophilia B Treated by IdElvion®

Who this might be right for
Haemophilia B
CSL Behring 222
Post-approval studies (Phase 4)UnknownNCT04534751
What this trial is testing

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Who this might be right for
Traumatic HemorrhageCoagulopathyMassive Hemorrhage
University Health Network, Toronto 350
Not applicableStudy completedNCT01510418
What this trial is testing

Socialization of Adult Men With Congenital Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Dana-Farber Cancer Institute 27
Large-scale testing (Phase 3)Study completedNCT01395810
What this trial is testing

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 71
Not applicableStudy completedNCT00581438
What this trial is testing

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

Who this might be right for
Hemophilia AHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 52
Large-scale testing (Phase 3)Study completedNCT00141843
What this trial is testing

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation